NEOPS
LIVE

Serial Number

98323715

Owner

Personalis, Inc

Attorney

Laura Miller

Filing Date

Dec 20, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NEOPS Trademark

Serial Number: 98323715

NEOPS is a trademark filed by Personalis, Inc on December 20, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Personalis, Inc (52 trademarks)

Menlo Park, CA 94025

Entity Type: 03

Trademark Details

Filing Date

December 20, 2023

Registration Date

Not Registered

Published for Opposition

January 7, 2025

Goods & Services

Diagnostic biomarker reagents for medical purposes

Providing medical genomics testing and reporting services in the field of biomarkers for the susceptibility, risk, diagnosis, prognosis, treatment or management of cancer and other diseases; medical information services, namely, providing biomarker scores for treatment and diagnostic information

Providing data analysis and interpretation of nucleic-acid sequence data and analyzing and sequencing nucleic acids and other biological molecules to identify biomarkers usable for medical diagnosis and treatment, and scientific and medical research and design services relating to the sequencing nucleic acids and other biological molecules, all in the field of bioinformatics, genomics and gene expression research and development

Filing History

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 29, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 12, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 12, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 12, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 21, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 6, 2024 NWOS
NEW APPLICATION ENTERED
Dec 20, 2023 NWAP